Lobe Sciences Ltd. (CVE:LOBE) | WebDisclosure

Basculer en Français

9480	Companies
185531	Keywords
117925	Articles
99377	Press releases

Home
Companies
Lobe Sciences Ltd.

PRESS RELEASE

published on 07/29/2025 at 06:08, 4 months 7 days ago

Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
Lobe Sciences partners with ArcStone Securities to enhance capital market strategy, aiming to increase visibility and deliver shareholder value through scientific innovation and strategic collaboration in North American markets

Capital Markets Biopharmaceutical Investment Community Lobe Sciences ArcStone Securities
BRIEF

published on 07/17/2025 at 04:00, 4 months 19 days ago

Lobe Sciences Ltd. règle sa dette avec Gibbsons PC

Règlement De La Dette Traitements Innovants Émission D'actions Ordinaires Société Biopharmaceutique Valeurs Mobilières Canadiennes
BRIEF

published on 07/17/2025 at 04:00, 4 months 19 days ago

Lobe Sciences Ltd. Settles Debt with Gibbsons P.C.

Common Shares Issuance Debt Settlement Biopharmaceutical Company Canadian Securities Innovative Treatments
PRESS RELEASE

published on 07/17/2025 at 03:55, 4 months 19 days ago

Lobe Sciences Ltd. Announces Debt Settlement
Lobe Sciences settles debt with Gibbsons Law P.C. by issuing 546,206 common shares at CAD$0.02123/share. The shares were issued on May 13, 2025, subject to regulatory hold periods

Common Shares Debt Settlement Biopharmaceutical Lobe Sciences Regulatory Hold Periods
BRIEF

published on 07/08/2025 at 06:06, 4 months 28 days ago

Lobe Sciences Secures European Patent for Sickle Cell Disease Treatment

European Patent Sickle Cell Disease DHA Composition Altemia® Biopharmaceutical Expansion
BRIEF

published on 07/08/2025 at 06:06, 4 months 28 days ago

Lobe Sciences obtient un brevet européen pour un traitement contre la drépanocytose

Brevet Européen Drépanocytose Altemia® Composition Du DHA Expansion Biopharmaceutique
PRESS RELEASE

published on 07/08/2025 at 06:01, 4 months 28 days ago

Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
Lobe Sciences secures European Unitary Patent EP4117446 across 17 EU member states for innovative Altemia(R) Medical Food Formula designed to manage Sickle Cell Disease, supporting global expansion strategy

Global Expansion Lobe Sciences Sickle Cell Disease European Unitary Patent Altemia Medical Food Formula
BRIEF

published on 06/18/2025 at 06:03, 5 months 17 days ago

Lobe Sciences fait progresser le développement de la psilocine conjuguée avec Cynaptec Spin-Out

Cynaptec Pharmaceuticals Psilocine Conjuguée Céphalées En Grappe Chroniques Drépanocytose Investissements Biopharmaceutiques
BRIEF

published on 06/18/2025 at 06:03, 5 months 17 days ago

Lobe Sciences Advances Conjugated Psilocin Development with Cynaptec Spin-Out

Conjugated Psilocin Cynaptec Pharmaceuticals Chronic Cluster Headaches Sickle Cell Disease Biopharmaceutical Investments
PRESS RELEASE

published on 06/18/2025 at 05:58, 5 months 17 days ago

Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
Lobe Sciences Ltd. advances Conjugated Psilocin™ research for chronic cluster headaches and addiction via $6M investment in Cynaptec Pharmaceuticals, with option for additional $20M

Clinical Trials Investment Cynaptec Pharmaceuticals Lobe Sciences Ltd. Conjugated Psilocin™

Accesswire

Published on 12/05/2025 at 19:20, 24 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 59 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 24 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 44 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 29 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 45 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 17 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 28 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 52 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 57 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 26 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 26 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 33 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 33 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 45 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE